Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,328,713
+$932,706 QoQ
Shares Held
23,884
+22.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026HARBOUR INVESTMENTS, INC. holds $117,796,291 across 17 Drug Manufacturers - General names. GILD ranks #6 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
228,025 | $49,593,157 | |
| 2 | LLY |
ELI LILLY & Co
|
27,501 | $25,294,594 | |
| 3 | JNJ |
Johnson & Johnson
|
79,700 | $19,481,868 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,030 | $4,815,208 | |
| 5 | PFE |
Pfizer Inc
|
143,430 | $4,027,514 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
23,884 | $3,328,713 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
52,185 | $3,165,020 | |
| 8 | AMGN |
Amgen Inc
|
8,658 | $3,046,317 |
All Filings in GILD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,328,713 | 23,884 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,396,007 | 19,521 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $794,316 | 7,156 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $809,794 | 7,304 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $826,144 | 7,373 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $737,759 | 7,987 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $678,265 | 8,090 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $621,263 | 9,055 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $514,068 | 7,018 | Shares | Sole | 2024-07-22 | |
| 2023-12-31 | $539,526 | 6,660 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $465,452 | 6,211 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $509,432 | 6,610 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $549,676 | 6,625 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $541,971 | 6,313 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $285,069 | 4,621 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $285,624 | 4,621 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $338,580 | 4,663 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $1,012,755 | 14,499 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,166,970 | 16,947 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $918,780 | 14,216 | Shares | Sole | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||